Riedl J - Search Results

1

Association of programmed cell death ligand 1 and circulating lymphocytes with risk of venous thromboembolism in patients with glioma.

Mir Seyed Nazari P, Berghoff AS, Preusser M, Moik F, Posch F, Ricken G, Riedl J, Hell L, Marosi C, Hainfellner JA, Pabinger I, Ay C. Mir Seyed Nazari P, et al. Among authors: riedl j. ESMO Open. 2020 May;5(3):e000647. doi: 10.1136/esmoopen-2019-000647. ESMO Open. 2020. PMID: 32424065 Free PMC article.

2

Platelets in cancer and thrombosis.

Riedl J, Pabinger I, Ay C. Riedl J, et al. Hamostaseologie. 2014;34(1):54-62. doi: 10.5482/HAMO-13-10-0054. Epub 2013 Dec 5. Hamostaseologie. 2014. PMID: 24305775 Review.

3

Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Results from the Vienna Cancer and Thrombosis Study (CATS).

Riedl J, Kaider A, Reitter EM, Marosi C, Jäger U, Schwarzinger I, Zielinski C, Pabinger I, Ay C. Riedl J, et al. Thromb Haemost. 2014 Apr 1;111(4):670-8. doi: 10.1160/TH13-07-0603. Epub 2013 Dec 5. Thromb Haemost. 2014. PMID: 24306221

4

Red cell distribution width and other red blood cell parameters in patients with cancer: association with risk of venous thromboembolism and mortality.

Riedl J, Posch F, Königsbrügge O, Lötsch F, Reitter EM, Eigenbauer E, Marosi C, Schwarzinger I, Zielinski C, Pabinger I, Ay C. Riedl J, et al. PLoS One. 2014 Oct 27;9(10):e111440. doi: 10.1371/journal.pone.0111440. eCollection 2014. PLoS One. 2014. PMID: 25347577 Free PMC article.

5

Association of platelet activation markers with cancer-associated venous thromboembolism.

Riedl J, Hell L, Kaider A, Koder S, Marosi C, Zielinski C, Panzer S, Pabinger I, Ay C. Riedl J, et al. Platelets. 2016;27(1):80-5. doi: 10.3109/09537104.2015.1041901. Epub 2015 May 13. Platelets. 2016. PMID: 25970326 Free article.

6

Platelet-specific markers are associated with monocyte-platelet aggregate formation and thrombin generation potential in advanced atherosclerosis.

Gremmel T, Ay C, Riedl J, Kopp CW, Eichelberger B, Koppensteiner R, Panzer S. Gremmel T, et al. Among authors: riedl j. Thromb Haemost. 2016 Mar;115(3):615-21. doi: 10.1160/TH15-07-0598. Epub 2015 Oct 15. Thromb Haemost. 2016. PMID: 26467184

7

Hypercoagulabilty, venous thromboembolism, and death in patients with cancer. A Multi-State Model.

Posch F, Riedl J, Reitter EM, Kaider A, Zielinski C, Pabinger I, Ay C. Posch F, et al. Among authors: riedl j. Thromb Haemost. 2016 Apr;115(4):817-26. doi: 10.1160/TH15-09-0758. Epub 2016 Jan 7. Thromb Haemost. 2016. PMID: 26738412

8

Alterations of blood coagulation in controlled human malaria infection.

Riedl J, Mordmüller B, Koder S, Pabinger I, Kremsner PG, Hoffman SL, Ramharter M, Ay C. Riedl J, et al. Malar J. 2016 Jan 7;15:15. doi: 10.1186/s12936-015-1079-3. Malar J. 2016. PMID: 26743539 Free PMC article. Clinical Trial.

9

Association Between Decreased Serum Albumin With Risk of Venous Thromboembolism and Mortality in Cancer Patients.

Königsbrügge O, Posch F, Riedl J, Reitter EM, Zielinski C, Pabinger I, Ay C. Königsbrügge O, et al. Among authors: riedl j. Oncologist. 2016 Feb;21(2):252-7. doi: 10.1634/theoncologist.2015-0284. Epub 2016 Jan 13. Oncologist. 2016. PMID: 26764252 Free PMC article.

10

A new measure for in vivo thrombin activity in comparison with in vitro thrombin generation potential in patients with hyper- and hypocoagulability.

Königsbrügge O, Koder S, Riedl J, Panzer S, Pabinger I, Ay C. Königsbrügge O, et al. Among authors: riedl j. Clin Exp Med. 2017 May;17(2):251-256. doi: 10.1007/s10238-016-0417-2. Epub 2016 Apr 19. Clin Exp Med. 2017. PMID: 27094310 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters